Press "Enter" to skip to content

Moderna, largest biotech to go public, fails to impress in market debut

At that opening price, Moderna was valued at $7.32 billion, based on 332.9 million outstanding shares including over-allotment, making it the biggest biotech company to go public.

Original source:

Also Read:   Sun Pharma, US-based Rockwell Medical enter into licensing pact for Triferic in India